Inclusion of pregnant and lactating persons in clinical trials : proceedings of a workshop / Theresa Wizemann, Andrew March, and Carolyn Shore, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division
Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription medication during their pregnancy. Yet, due to a number of historical, ethical, legal, scientific, and societal issues, pregnant and lactating persons are often excluded from clinical trials. As a result, pregnant and lactating persons are often taking drugs based on limited information about the benefits and risks to themselves and their developing or newborn baby. The National Academies Forum on Drug Discovery, Development, and Translation convened a workshop in June 2022 for stakeholders to examine the current state of evidence generation for drug products used by pregnant and lactating persons and discuss barriers and opportunities for including these populations in clinical trials. This publication summarizes the presentations and discussion of the workshop..
| Medienart: |
E-Book |
|---|
| Erscheinungsjahr: |
[2023] |
|---|---|
| Erschienen: |
Washington, DC: National Academies Press ; 2023 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Wizemann, Theresa M. [VerfasserIn] |
|---|
| Links: |
www.ncbi.nlm.nih.gov [teilw. kostenfrei] |
|---|
| ISBN: |
|---|
| Themen: |
Clinical Trials as Topic |
|---|
| Anmerkungen: |
Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed Spetember27, 2023) |
|---|
| Umfang: |
1 online resource (1 PDF file (xviii, 127 pages)) |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
1860745962 |
|---|
| LEADER | 01000cam a22002652 4500 | ||
|---|---|---|---|
| 001 | 1860745962 | ||
| 003 | DE-627 | ||
| 005 | 20231101191538.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231005s2022 xx |||||o 00| ||eng c | ||
| 020 | |a 9780309696371 |9 978-0-309-69637-1 | ||
| 020 | |a 0309696372 |9 0-309-69637-2 | ||
| 035 | |a (DE-627)1860745962 | ||
| 035 | |a (DE-599)KEP096623411 | ||
| 035 | |a (OCoLC)1407070096 | ||
| 035 | |a (NCBI)9918628878406676 | ||
| 035 | |a (EBP)096623411 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 100 | 1 | |a Wizemann, Theresa M. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Inclusion of pregnant and lactating persons in clinical trials |b proceedings of a workshop |c Theresa Wizemann, Andrew March, and Carolyn Shore, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division |
| 264 | 1 | |a Washington, DC |b National Academies Press |c [2023] | |
| 300 | |a 1 online resource (1 PDF file (xviii, 127 pages)) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Includes bibliographical references. - Description based on online resource; title from PDF title page (viewed Spetember27, 2023) | ||
| 520 | |a Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription medication during their pregnancy. Yet, due to a number of historical, ethical, legal, scientific, and societal issues, pregnant and lactating persons are often excluded from clinical trials. As a result, pregnant and lactating persons are often taking drugs based on limited information about the benefits and risks to themselves and their developing or newborn baby. The National Academies Forum on Drug Discovery, Development, and Translation convened a workshop in June 2022 for stakeholders to examine the current state of evidence generation for drug products used by pregnant and lactating persons and discuss barriers and opportunities for including these populations in clinical trials. This publication summarizes the presentations and discussion of the workshop. | ||
| 650 | 2 | |a Clinical Trials as Topic | |
| 650 | 2 | |a Pregnant Women | |
| 650 | 2 | |a Lactation |x drug effects | |
| 650 | 2 | |a Pregnancy |x drug effects | |
| 650 | 2 | |a Patient Selection | |
| 650 | 2 | |a Therapeutic Human Experimentation | |
| 650 | 2 | |a Risk Assessment | |
| 651 | 2 | |a United States | |
| 655 | 2 | |a Congress | |
| 700 | 1 | |a March, Andrew |e verfasserin |4 aut | |
| 700 | 1 | |a Shore, Carolyn |e verfasserin |4 aut | |
| 710 | 2 | |a National Academies of Sciences, Engineering, and Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation, |e MitwirkendeR |4 ctb | |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/books/NBK587623/ |m X:NCBI |x Verlag |z teilw. kostenfrei |
| 912 | |a ZDB-193-NCB | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a ISIL_DE-18 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a GBV_ILN_22_i06404 | ||
| 912 | |a GBV_ILN_40 | ||
| 912 | |a ISIL_DE-7 | ||
| 912 | |a GBV_ILN_74 | ||
| 912 | |a ISIL_DE-354 | ||
| 912 | |a GBV_ILN_2003 | ||
| 912 | |a ISIL_DE-25 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a ISIL_DE-180 | ||
| 912 | |a GBV_ILN_2010 | ||
| 912 | |a ISIL_DE-15 | ||
| 951 | |a BO | ||
| 980 | |2 22 |1 01 |x 0018 |b 4382653452 |h h64 NCBI |y zi06404 |z 08-10-23 | ||
| 980 | |2 40 |1 01 |x 0007 |b 4382652979 |h OLR-NCB-BOOKSHELF |y xsn |z 08-10-23 | ||
| 980 | |2 74 |1 01 |x 0354 |b 4382652480 |c 09 |f E-Bibl |d EM 0000 |e --%%-- |j --%%-- |y ze |z 08-10-23 | ||
| 980 | |2 2003 |1 01 |x DE-25 |b 4381389573 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 05-10-23 | ||
| 980 | |2 2009 |1 01 |x DE-180 |b 4381390326 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 05-10-23 | ||
| 980 | |2 2010 |1 01 |x DE-15 |b 4381390334 |c 00 |f --%%-- |d --%%-- |e --%%-- |j n |k Elektronischer Volltext - Open Access |y l01 |z 05-10-23 | ||
| 981 | |2 22 |1 01 |x 0018 |r https://www.ncbi.nlm.nih.gov/books/NBK587623/ | ||
| 981 | |2 40 |1 01 |x 0007 |y Volltext, Open Access |r https://www.ncbi.nlm.nih.gov/books/NBK587623/ | ||
| 981 | |2 74 |1 01 |x 0354 |r https://www.ncbi.nlm.nih.gov/books/NBK587623/ | ||
| 981 | |2 2003 |1 01 |x DE-25 |r https://www.ncbi.nlm.nih.gov/books/NBK587623/ | ||
| 981 | |2 2010 |1 01 |x DE-15 |y Online-Zugriff |r https://www.ncbi.nlm.nih.gov/books/NBK587623/ | ||
| 985 | |2 22 |1 01 |x 0018 |a h64 ebook | ||
| 985 | |2 74 |1 01 |x 0354 |a EM 0000 | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 NCBI | ||
| 995 | |2 22 |1 01 |x 0018 |a h64 freie Ressource | ||
| 995 | |2 40 |1 01 |x 0007 |a OLR-NCB-BOOKSHELF | ||